Mascoma Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.2K | Sell |
495
-50
| -9% | -$4.46K | 0.01% | 183 |
|
|
2026
Q1 | $39.1K | Buy |
545
+3
| +0.6% | +$231 | 0.01% | 210 |
|
|
2025
Q4 | $43K | Buy |
542
+19
| +4% | +$1.5K | 0.01% | 194 |
|
|
2025
Q3 | $39.4K | Hold |
523
| – | – | 0.01% | 209 |
|
|
2025
Q2 | $36.1K | Sell |
523
-200
| -28% | -$13.1K | 0.01% | 217 |
|
|
2025
Q1 | $49K | Hold |
723
| – | – | 0.01% | 190 |
|
|
2024
Q4 | $32.5K | Sell |
723
-667
| -48% | -$37.4K | 0.01% | 236 |
|
|
2024
Q3 | $87.4K | Hold |
1,390
| – | – | 0.02% | 150 |
|
|
2024
Q2 | $82.1K | Sell |
1,390
-100
| -7% | -$6.25K | 0.02% | 151 |
|
|
2024
Q1 | $119K | Hold |
1,490
| – | – | 0.03% | 125 |
|
|
2023
Q4 | $118K | Sell |
1,490
-35
| -2% | -$2.49K | 0.04% | 127 |
|
|
2023
Q3 | $106K | Buy |
1,525
+35
| +2% | +$2.48K | 0.03% | 132 |
|
|
2023
Q2 | $110K | Sell |
1,490
-33
| -2% | -$2.35K | 0.03% | 131 |
|
|
2023
Q1 | $112K | Sell |
1,523
-221
| -13% | -$18.5K | 0.03% | 158 |
|
|
2022
Q4 | $163K | Hold |
1,744
| – | – | 0.05% | 126 |
|
|
2022
Q3 | $166K | Hold |
1,744
| – | – | 0.06% | 123 |
|
|
2022
Q2 | $162K | Sell |
1,744
-75
| -4% | -$7.32K | 0.06% | 125 |
|
|
2022
Q1 | $184K | Buy |
1,819
+46
| +3% | +$4.83K | 0.06% | 127 |
|
|
2021
Q4 | $183K | Buy |
1,773
+5
| +0.3% | +$462 | 0.06% | 112 |
|
|
2021
Q3 | $150K | Buy |
+1,768
| New | +$148K | 0.06% | 121 |
|
|
2021
Q2 | – | Sell |
-1,735
| Closed | -$131K | – | 176 |
|
|
2021
Q1 | $131K | Buy |
+1,735
| New | +$126K | 0.06% | 130 |
|
|
2019
Q3 | – | Sell |
-271
| Closed | -$15K | – | 133 |
|
|
2019
Q2 | $15K | Sell |
271
-12
| -4% | -$646 | 0.01% | 242 |
|
|
2019
Q1 | $15K | Sell |
283
-40
| -12% | -$2.47K | 0.01% | 242 |
|
|
2018
Q4 | $21K | Buy |
323
+48
| +17% | +$3.58K | 0.02% | 207 |
|
|
2018
Q3 | $22K | Hold |
275
| – | – | 0.01% | 227 |
|
|
2018
Q2 | $18K | Sell |
275
-195
| -41% | -$12.9K | 0.01% | 228 |
|
|
2018
Q1 | $29K | Hold |
470
| – | – | 0.02% | 191 |
|
|
2017
Q4 | $36K | Buy |
470
+40
| +9% | +$2.91K | 0.02% | 164 |
|
|
2017
Q3 | $35K | Hold |
430
| – | – | 0.02% | 174 |
|
|
2017
Q2 | $35K | Hold |
430
| – | – | 0.02% | 182 |
|
|
2017
Q1 | $34K | Sell |
430
-53
| -11% | -$4.23K | 0.02% | 172 |
|
|
2016
Q4 | $38K | Buy |
+483
| New | +$39.1K | 0.03% | 163 |
|
Other funds holding CVS
Mascoma Wealth Management's CVS Position: Q2 2026 in Review
Mascoma Wealth Management reduced its CVS Health (CVS) stake by 9.2% in Q2 2026, selling an estimated $4.46K and leaving 495 shares worth $51.2K. The position accounts for 0.01% of the portfolio, ranked #183.
Mascoma Wealth Management first reported a position in CVS in Q4 2016 and has held it in 32 quarters since. The position peaked at $184K in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Mascoma Wealth Management held 495 shares of CVS Health worth $51.2K as of Q2 2026.
- Mascoma Wealth Management sold 50 CVS Health shares in Q2 2026, an estimated $4.46K.
- CVS Health made up 0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #183 holding.
- Mascoma Wealth Management first reported a position in CVS Health in Q4 2016 and has held it in 32 quarters since.
- Mascoma Wealth Management's CVS Health position peaked at $184K in Q1 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.